Suffolk Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-24,020
| Closed | -$1.46M | – | 140 |
|
|
2016
Q3 | $1.46M | Sell |
24,020
-7,633
| -24% | -$463K | 0.2% | 96 |
|
|
2016
Q2 | $2.08M | Buy |
31,653
+2,578
| +9% | +$170K | 0.27% | 115 |
|
|
2016
Q1 | $1.65M | Buy |
29,075
+17,927
| +161% | +$1.02M | 0.22% | 128 |
|
|
2015
Q4 | $2.62M | Buy |
11,148
+2,727
| +32% | +$641K | 0.33% | 90 |
|
|
2015
Q3 | $1.33M | Buy |
8,421
+1,856
| +28% | +$293K | 0.18% | 125 |
|
|
2015
Q2 | $2.48M | Buy |
6,565
+1,361
| +26% | +$515K | 0.3% | 109 |
|
|
2015
Q1 | $2.18M | Sell |
5,204
-6,033
| -54% | -$2.52M | 0.26% | 118 |
|
|
2014
Q4 | $3.08M | Buy |
11,237
+920
| +9% | +$252K | 0.37% | 77 |
|
|
2014
Q3 | $2.01M | Buy |
10,317
+1,206
| +13% | +$234K | 0.25% | 116 |
|
|
2014
Q2 | $2.23M | Buy |
9,111
+1,534
| +20% | +$375K | 0.27% | 115 |
|
|
2014
Q1 | $2.01M | Sell |
7,577
-167
| -2% | -$44.3K | 0.25% | 121 |
|
|
2013
Q4 | $2.81M | Buy |
7,744
+1,787
| +30% | +$649K | 0.35% | 95 |
|
|
2013
Q3 | $3.17M | Sell |
5,957
-2,754
| -32% | -$1.46M | 0.43% | 71 |
|
|
2013
Q2 | $2.04M | Buy |
+8,711
| New | +$2.04M | 0.29% | 117 |
|